Herman GA, O'Brien MP, Forleo-Neto E, et al. Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2022; published online July 5. https://doi.org/10.1016/S1473-3099(22)00416-9—In this Article, the y-axis values of figure 1 were corrected. This correction has been made to the online version as of July 15, 2022, and will be made to the printed version.
. 2022 Jul 15;22(9):e239. doi: 10.1016/S1473-3099(22)00501-1
Correction to Lancet Infect Dis 2022; published online July 5. https://doi.org/10.1016/S1473-3099(22)00416-9
Issue date 2022 Sep.
© 2022 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9286701 PMID: 35850126